JPX · 194A.T
WOLVES HAND Co., Ltd.
¥1,498-¥4 (-0.27%)
WOLVES HAND Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 48.34% below the high.
Loading market information…
JPX · 4512.T · JPY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · JPY. Historical prices are not a forecast.
Wakamoto Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 20.26% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Wakamoto Pharmaceutical Co.,Ltd.’s forward annual dividend is ¥4 per share, paid annual. The forward yield is 1.16% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Wakamoto Pharmaceutical Co.,Ltd.’s next earnings report is currently expected on Nov 6, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Wakamoto Pharmaceutical Co.,Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Headquartered in Tokyo, Japan, Wakamoto Pharmaceutical Co., Ltd. specializes in the production and distribution of both prescription and over-the-counter pharmaceuticals across the country. Their diverse offerings include Strong Wakamoto, a widely recognized gastrointestinal aid formulated to enhance digestion, regulate intestinal health, and supplement nutrition. Additionally, the company provides AVANTBISE oral tablets, a dietary supplement designed to rebalance the oral microbiome, as well as various medicated toothpastes. Founded in 1929, the enterprise was initially known as Society for Nutrition and Raising Children Co., Ltd. before formally changing its name to Wakamoto Pharmaceutical Co., Ltd. in July 1943.
Latest available per-share figures in JPY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:08 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
THE ANALYST VIEW
11 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
¥1,498-¥4 (-0.27%)
WOLVES HAND Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 48.34% below the high.
¥435-¥2 (-0.46%)
JMS Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 9.0% below the high.
¥1,950+¥1 (+0.05%)
J Frontier Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 6.92% below the high.
¥585-¥2 (-0.34%)
GENOVA, Inc.’s quoted price sits in the lower half of its reported 52-week range, 13.33% below the high.
¥2,195-¥23 (-1.04%)
Morishita Jintan Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 8.16% below the high.
¥1,443-¥44 (-2.96%)
JTEC Corporation’s quoted price sits in the lower half of its reported 52-week range, 42.6% below the high.
¥27-¥1 (-3.57%)
Solasia Pharma K.K.’s quoted price sits in the lower half of its reported 52-week range, 35.71% below the high.
¥1,884+¥9 (+0.48%)
AS Partners Co. Ltd.’s quoted price sits in the lower half of its reported 52-week range, 36.48% below the high.
